KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other financing activities (2016 - 2026)

Eli Lilly filings provide 16 years of Other financing activities readings, the most recent being -$591.0 million for Q1 2026.

  • On a quarterly basis, Other financing activities rose 13.85% to -$591.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$677.0 million, a 14.0% increase, with the full-year FY2025 number at -$772.0 million, down 57.23% from a year prior.
  • Other financing activities hit -$591.0 million in Q1 2026 for Eli Lilly, down from -$25.1 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of -$5.2 million in Q3 2022 to a low of -$686.0 million in Q1 2025.
  • Median Other financing activities over the past 5 years was -$30.7 million (2025), compared with a mean of -$146.9 million.
  • The widest YoY moves for Other financing activities: up 48.99% in 2022, down 2183.33% in 2022.
  • Eli Lilly's Other financing activities stood at -$13.7 million in 2022, then plummeted by 130.66% to -$31.6 million in 2023, then crashed by 45.25% to -$45.9 million in 2024, then surged by 45.32% to -$25.1 million in 2025, then tumbled by 2254.58% to -$591.0 million in 2026.
  • The last three reported values for Other financing activities were -$591.0 million (Q1 2026), -$25.1 million (Q4 2025), and -$30.2 million (Q3 2025) per Business Quant data.